Thermo Fisher Scientific Expands its Global Biologics and Steriles Manufacturing Capabilities in China
Search Patheon
Recent searches
Clear History
Suggestions
All Results
Recent searches
Clear History
Suggestions
All Results
Search
US | EN
The emergence of mRNA therapeutics including the development of new vaccines and gene therapies has created a market constraint on access to critical raw materials and technical expertise. Thermo Fisher Scientific understands pharmaceutical services and has worked to integrate our capabilities across the nucleic acids operational value chain to enable you to move your mRNA therapeutic from development to commercialization.
Learn more about mRNA manufacturing services by downloading our capabilities fact sheet.